SHIM
ROIV icon

Stone House Investment Management’s Roivant Sciences ROIV Stock Holding History

Stone House Investment Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$885 Hold
25
– – ﹤0.01% 907
2026
Q1 		$693 Hold
25
– – ﹤0.01% 760
2025
Q4 		$543 Hold
25
– – ﹤0.01% 718
2025
Q3 		$378 Hold
25
– – ﹤0.01% 683
2025
Q2 		$282 Buy
+25
New +$271 ﹤0.01% 498

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Stone House Investment Management's ROIV Position: Q2 2026 in Review

Stone House Investment Management held its Roivant Sciences (ROIV) position steady in Q2 2026 at 25 shares worth $885. The position accounts for ﹤0.01% of the portfolio, ranked #907.

Stone House Investment Management first reported a position in ROIV in Q2 2025 and has held it in 5 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Stone House Investment Management held 25 shares of Roivant Sciences worth $885 as of Q2 2026.
  • Stone House Investment Management left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #907 holding.
  • Stone House Investment Management first reported a position in Roivant Sciences in Q2 2025 and has held it in 5 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.